SAL056

· Shenzhen Salubris Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAL056, covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk [Phase 3]

See pricing